Cold, dry air is the ideal climate for viruses like the flu, phenomena and Respiratory Syncytial Virus (RSV), and these low ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

The NHS is urging eligible patients to protect themselves this winter by getting vaccinated against respiratory syncytial ...

For a few years, the second seasonal COVID-19 spike has been accompanied by rising cases of seasonal flu and RSV in what ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Chatham-Kent health agencies urge the public to take advantage of the flu and COVID-19 vaccines and RSV (respiratory ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.